Discover
the leader in artificial disc replacement surgeries
Artificial disc replacement surgery
Texas Back Institute offers a variety of
innovative artificial disk procedures. The vast experience of our
surgeons allow them to select the treatment that will provide the
best outcome possible for each patient's unique condition.
Unlike a fusion, both of these
artificial discs
allow our
surgeons to relieve pain and
preserve motion in your
spine,
because they are designed to
move like your body’s own
spinal
discs.
If you have been advised to
have a fusion,
please contact our team at Texas Back Institute
for an evaluation to
find out if you are a candidate for one of these advanced artificial
discs.
We offer the most extensive experience in the
two FDA approved lumbar disc replacements, the CHARITE and ProDisc-L
artificial discs. Texas Back Institute was the highest enrolling
research for both of these treatments. In fact, the first CHARITE and
the first ProDisc-L in the United States were implanted by surgeons
here at Texas Back Institute.
With almost 7 years of experience in artificial
disc surgery, our surgeons are trusted to teach these procedures to
other respected surgeons from around the country. We also have the
expertise and experience in performing multi-level and hybrid
surgeries when replacement of two or more spinal discs is necessary.
Highlights of our
experience:
Have implanted more artificial discs than any
other clinic in the United States
First to perform artificial disc surgery in the
United States in March 2000
First to implant both the CHARITE and ProDisc
in the United States
Every surgeon at Texas Back Institute is
trained in arthroplasty (artificial disc replacement)
Our Spine Arthroplasty Fellowship, supported by
DePuy Spine, is the first training program of its kind
The highest enrolling site for the FDA studies
of both CHARITE and ProDisc-L
Dr. Scott Blumenthal
was the lead investigator for the CHARITE FDA trials and the lead
author on the published results in the Spine journal
Dr.
Jack Zigler was the lead investigator for the
Prodisc-L FDA trials and the lead author on the published results in
the Spine journal
|
